Negative conversion of T-SPOT results after hemodialysis: case series and literature review

IF 0.9 Q4 UROLOGY & NEPHROLOGY
Masataro Toda, Ayumi Yoshifuji, Koji Hosoya, Motoaki Komatsu, Naoki Hasegawa, Munekazu Ryuzaki
{"title":"Negative conversion of T-SPOT results after hemodialysis: case series and literature review","authors":"Masataro Toda, Ayumi Yoshifuji, Koji Hosoya, Motoaki Komatsu, Naoki Hasegawa, Munekazu Ryuzaki","doi":"10.1186/s41100-023-00510-2","DOIUrl":null,"url":null,"abstract":"Abstract Background Latent tuberculosis infection (LTBI) affects 11.9% of outpatients under maintenance hemodialysis in Japan. In addition, the risk of reactivation of LTBI in hemodialysis patients is up to 10–25 times higher than that in the general population. Therefore, the accurate diagnosis and treatment for LTBI are extremely important. The interferon-γ release assays are widely used for screening LTBI; however, the impact of hemodialysis on the assay results has been uncertain. Case presentation Twenty-seven hemodialysis patients (17 males, 69.9 ± 10.1 year old) were performed T-SPOT ® .TB test (T-SPOT) both before and after hemodialysis. In cases where T-SPOT results were different before and after hemodialysis, T-SPOT was re-evaluated in a same manner. As a result, two cases showed consistent T-SPOT diagnostic discrepancy before and after hemodialysis in two measurements. In the first case, T-SPOT was indeterminate/positive before hemodialysis, but changed to negative after hemodialysis. In the second case, T-SPOT was positive before hemodialysis, but changed to indeterminate after hemodialysis. Conclusions We experienced the negative conversion of T-SPOT after hemodialysis in cases of LTBI. T-SPOT may show false-negative when measured after hemodialysis due to immunomodulation caused by hemodialysis.","PeriodicalId":21028,"journal":{"name":"Renal Replacement Therapy","volume":"48 ","pages":"0"},"PeriodicalIF":0.9000,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Renal Replacement Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s41100-023-00510-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Background Latent tuberculosis infection (LTBI) affects 11.9% of outpatients under maintenance hemodialysis in Japan. In addition, the risk of reactivation of LTBI in hemodialysis patients is up to 10–25 times higher than that in the general population. Therefore, the accurate diagnosis and treatment for LTBI are extremely important. The interferon-γ release assays are widely used for screening LTBI; however, the impact of hemodialysis on the assay results has been uncertain. Case presentation Twenty-seven hemodialysis patients (17 males, 69.9 ± 10.1 year old) were performed T-SPOT ® .TB test (T-SPOT) both before and after hemodialysis. In cases where T-SPOT results were different before and after hemodialysis, T-SPOT was re-evaluated in a same manner. As a result, two cases showed consistent T-SPOT diagnostic discrepancy before and after hemodialysis in two measurements. In the first case, T-SPOT was indeterminate/positive before hemodialysis, but changed to negative after hemodialysis. In the second case, T-SPOT was positive before hemodialysis, but changed to indeterminate after hemodialysis. Conclusions We experienced the negative conversion of T-SPOT after hemodialysis in cases of LTBI. T-SPOT may show false-negative when measured after hemodialysis due to immunomodulation caused by hemodialysis.
血液透析后T-SPOT结果的负转换:病例系列和文献回顾
背景潜伏结核感染(LTBI)影响了11.9%的日本维持性血液透析门诊患者。此外,血液透析患者LTBI再激活的风险比一般人群高10-25倍。因此,对LTBI的准确诊断和治疗是极其重要的。干扰素γ释放试验被广泛用于筛选LTBI;然而,血液透析对测定结果的影响尚不确定。对27例血液透析患者(男性17例,年龄69.9±10.1岁)在血液透析前后进行T-SPOT®. tb检测(T-SPOT)。在血液透析前后T-SPOT结果不同的病例中,以相同的方式重新评估T-SPOT。结果,两个病例在血液透析前后的两次测量中显示一致的T-SPOT诊断差异。第一例患者在血液透析前T-SPOT为不确定/阳性,但在血液透析后变为阴性。在第二例患者中,T-SPOT在血液透析前呈阳性,但在血液透析后变为不确定。结论LTBI患者血液透析后T-SPOT出现负转化。由于血液透析引起的免疫调节,在血液透析后测量T-SPOT可能显示假阴性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Renal Replacement Therapy
Renal Replacement Therapy Medicine-Transplantation
CiteScore
1.70
自引率
8.30%
发文量
57
审稿时长
19 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信